PRESENTED BY:-
14-ARID-2022
METRONIDAZOLE + LUMINAL
SEVERE INTESTINAL AMEBICIDE
INFECTION DEHYDROEMETINE +
LUMINAL AMEBICIDE
METRONIDAZOLE OR
LIVER ABSCESS DEHYDROEMETINE OR
CHLOROQUINE PLUS
LUMINAL AMEBICIDE
ANTIMALARIAL DRUG
QUININE………………….Con
Parasite feeds on haemoglobin - Breaks down globin
proteins into a.a. in lysosomes - haeme converted to
a non-toxic product by parasite
Quinine accumulates in lysosome of parasite in RBC
Quinine binds to haeme and inhibits conversion of
haeme to non- toxic product
Haeme-quinine complex highly toxic to parasite
May function by disrupting lysosome membrane
QUININE:
QUININE complex with double stranded DNA to
prevent strand sepration.
Block replication of DNA and transcription to RNA.
CHLROQUINE…………….Con
Systemic or tissue amebcidese
Antimalarial drug
Used in combination for amebic liver diseases
MECHANISM OF ACTION:
The parasite produces the toxic and soluble molecule
heme. The parasite biocrystallizes heme to form
hemozoin, a non-toxic molecule. Hemozoin collects in the
digestive vacuole as insoluble crystals
Chloroquine enters the red blood cell, inhabiting parasite
cell
Chloroquine caps hemozoin molecules to prevent further
biocrystallization of heme.
Chloroquine binds to heme to form Chloroquine
complex; this complex is highly toxic to the cell and
disrupts membrane function.
Action of the toxic Chloroquine complex results in cell
lysis and ultimately parasite cell autodigestion.
CHLROQUINE:
It cause the inhibition of parasite digestive enzymes.
It decreased parasite growth.
inhibits digestion of haemoglobin.
MEFLOQUINE:
MECHANISM OF ACTION:
The ability of this agent to form a nitro-anion radical
metabolite, which reacts with the nucleic acids of the
parasite, causing a significant breakage in the
deoxyribonucleic acid (DNA).
The production of superoxide anions, and hence,
hydrogen peroxide (both of which are very toxic to
the parasite) and inhibition of trypanothione
reductase, which is a parasite-specific antioxidant
defense enzyme. Lack of these enzymes leads to
the accumulation of hydrogen peroxide to cytotoxic
levels, resulting in death of the parasite.
PENTAMIDINE:
MECHANISM OF ACTION:
The mode of action of pentamidine is not fully
understood.
Drug interferes with nuclear metabolism producing
inhibition of the synthesis of DNA, RNA,
phospholipids, and proteins.
Inhibitor of nucleic acid biosynthesis .
SURAMIN:
Mechanism Of Action:
Suramin works by blocking various growth processes
within the parasites. Specifically, the drug blocks
insulin growth, NADH oxidation enzyme, epidermal
growth, and platelet-derived growth, which limits cell
production and migration. When this happens, the
parasites become immobile and eventually die.
CHEMOTHERAPY FOR
LEISHMANIASIS
SODIUM STIBOGLUCONATE:
MECHANISM OF ACTION:
The mode of action of sodium stibogluconate is
unknown.
Inhibit parasite glycolysis and fatty acid oxidation,
leading to decreased energy and reduction in ATP
(adenosine triphosphate) and GTP (guanosine
triphosphate) synthesis contributes to decreased
macromolecular synthesis.
Decrease in parasite DNA, RNA protein.
CHEMOTHERAPY FOR
TOXOPLASMOSIS
PYRIMETHAMINE:
• No action against gametocytes.
MECHANISM OF ACTION:
interferes with folic acid synthesis by inhibiting
the enzyme dihydrofolate reductase (DHFR).
Folic acid is needed for DNA and RNA synthesis
in many species, including protozoa
CHEMOTHERAPY FOR GIARDIASIS
METRONIDAZOLE:
MECHANISM OF ACTION:
Metronidazole metabolites are taken up into bacterial
DNA, and form unstable molecules.
This function only occurs when metronidazole is
partially reduced.
Nitro group of metronidazole is reduced by protozoan
leading to cytotoxic reduced product that binds to DNA
and proteins resulting into parasite death